Seventeen-year follow-up of the prospective randomized Nordic CIS study

BCG monotherapy versus alternating therapy with mitomycin C and BCG in patients with carcinoma in situ of the urinary bladder

Eero Kaasinen , Hans Wijkstrom, Erkki Rintala, Oddvar Mestad, Staffan Jahnson, Per-Uno Malmstrom

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalScandinavian Journal of Urology
Volume50
Issue number5
Pages (from-to)360-368
Number of pages9
ISSN2168-1805
DOIs
Publication statusPublished - Oct 2016
MoE publication typeA1 Journal article-refereed

Fields of Science

  • BCG
  • carcinoma in situ
  • combination therapy
  • immunotherapy
  • instillation therapy
  • long-term efficacy
  • mitomycin C
  • randomized controlled trial
  • urinary bladder
  • BACILLUS-CALMETTE-GUERIN
  • PHASE-III TRIAL
  • ELECTROMOTIVE MITOMYCIN
  • UROTHELIAL CARCINOMA
  • PROGNOSTIC-FACTORS
  • CANCER
  • RISK
  • T1
  • MAINTENANCE
  • PROGRESSION
  • 3126 Surgery, anesthesiology, intensive care, radiology

Cite this

@article{08256084a10e40058b310837f711be22,
title = "Seventeen-year follow-up of the prospective randomized Nordic CIS study: BCG monotherapy versus alternating therapy with mitomycin C and BCG in patients with carcinoma in situ of the urinary bladder",
keywords = "BCG, carcinoma in situ, combination therapy, immunotherapy, instillation therapy, long-term efficacy, mitomycin C, randomized controlled trial, urinary bladder, BACILLUS-CALMETTE-GUERIN, PHASE-III TRIAL, ELECTROMOTIVE MITOMYCIN, UROTHELIAL CARCINOMA, PROGNOSTIC-FACTORS, CANCER, RISK, T1, MAINTENANCE, PROGRESSION, 3126 Surgery, anesthesiology, intensive care, radiology",
author = "Eero Kaasinen and Hans Wijkstrom and Erkki Rintala and Oddvar Mestad and Staffan Jahnson and Per-Uno Malmstrom",
year = "2016",
month = "10",
doi = "10.1080/21681805.2016.1210672",
language = "English",
volume = "50",
pages = "360--368",
journal = "Scandinavian Journal of Urology",
issn = "2168-1805",
publisher = "TAYLOR & FRANCIS LTD",
number = "5",

}

Seventeen-year follow-up of the prospective randomized Nordic CIS study : BCG monotherapy versus alternating therapy with mitomycin C and BCG in patients with carcinoma in situ of the urinary bladder. / Kaasinen , Eero; Wijkstrom, Hans; Rintala, Erkki; Mestad, Oddvar; Jahnson, Staffan; Malmstrom, Per-Uno.

In: Scandinavian Journal of Urology, Vol. 50, No. 5, 10.2016, p. 360-368.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Seventeen-year follow-up of the prospective randomized Nordic CIS study

T2 - BCG monotherapy versus alternating therapy with mitomycin C and BCG in patients with carcinoma in situ of the urinary bladder

AU - Kaasinen , Eero

AU - Wijkstrom, Hans

AU - Rintala, Erkki

AU - Mestad, Oddvar

AU - Jahnson, Staffan

AU - Malmstrom, Per-Uno

PY - 2016/10

Y1 - 2016/10

KW - BCG

KW - carcinoma in situ

KW - combination therapy

KW - immunotherapy

KW - instillation therapy

KW - long-term efficacy

KW - mitomycin C

KW - randomized controlled trial

KW - urinary bladder

KW - BACILLUS-CALMETTE-GUERIN

KW - PHASE-III TRIAL

KW - ELECTROMOTIVE MITOMYCIN

KW - UROTHELIAL CARCINOMA

KW - PROGNOSTIC-FACTORS

KW - CANCER

KW - RISK

KW - T1

KW - MAINTENANCE

KW - PROGRESSION

KW - 3126 Surgery, anesthesiology, intensive care, radiology

U2 - 10.1080/21681805.2016.1210672

DO - 10.1080/21681805.2016.1210672

M3 - Article

VL - 50

SP - 360

EP - 368

JO - Scandinavian Journal of Urology

JF - Scandinavian Journal of Urology

SN - 2168-1805

IS - 5

ER -